Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Edgewise Therapeutics Inc (EWTX)

  • Event
  • Oct. 27, 2022, 14:46 UTC
  • 118
  • 0 comments

Edgewise Therapeutics - Jett Foundation Community Webinar: Edgewise Therapeutics – A Novel Approach To Protect Muscle In Duchenne & Becker Muscular Dystrophy

Comment Full text

Geron Corporation Inc (GERN)

  • Event
  • Oct. 27, 2022, 14:37 UTC
  • 119
  • 0 comments

Geron - Q3 2022 Geron Earnings Conference Call

Comment Full text

Athersys Inc. (ATHX)

  • Event
  • Oct. 27, 2022, 14:12 UTC
  • 119
  • 0 comments

Athersys - Athersys Third Quarter 2022 Results Conference Call

Comment Full text

Seagen Inc (SGEN)

  • Event
  • Oct. 27, 2022, 14:10 UTC
  • 120
  • 0 comments

Seagen - Third Quarter 2022 Financial Results

Comment Full text

Gilead Sciences Inc (GILD)

  • Event
  • Oct. 27, 2022, 14:02 UTC
  • 110
  • 0 comments

Gilead - Q3 2022 Presentation

Comment Full text

IQVIA Holdings Inc. (IQV)

  • Event
  • Oct. 27, 2022, 13:09 UTC
  • 111
  • 0 comments

IQVIA Holdings Inc. Website - Validate Account

Comment Full text

IQVIA Holdings Inc. (IQV)

  • Event
  • Oct. 27, 2022, 13:09 UTC
  • 107
  • 0 comments

IQVIA Holdings Inc. Website - Validate Account

Comment Full text

Edgewise Therapeutics Inc (EWTX)

  • Event
  • Oct. 27, 2022, 11:28 UTC
  • 104
  • 0 comments

Edgewise Therapeutics - PPMD Community Webinar: Edgewise Therapeutics– A novel approach to protect muscle in Duchenne & Becker muscular dystrophy

Comment Full text

Electromed Inc. (ELMD)

  • Event
  • Oct. 27, 2022, 10:52 UTC
  • 105
  • 0 comments

SmartVest - Q1 FY 2023 Financial Results Conference Call

Comment Full text

Rain Therapeutics Inc (RAIN)

  • Event
  • Oct. 27, 2022, 06:01 UTC
  • 100
  • 0 comments

Rain Therapeutics to Report Third Quarter 2022 Financial Results and Highlights of Recent Progress on November 10, 2022

Comment Full text
  • Previous
  • 98
  • 99
  • 100
  • 101
  • 102
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189155)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124508)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin